study conducted evaluate use proton beam therapy treatment prostate cancer preliminary assessment morbidity tumor response sixteen patients prostate cancer underwent proton beam therapy acute late toxicity scored according national cancer institute common toxicity criteria grading version NUMBER april NUMBER radiation therapy oncology group grading respectively local control assessed using magnetic resonance imaging mri antigen psa values skin toxicity bladder irritability commonly observed patients developed grade iii iv toxicity NUMBER patients primary lesion detected mri partial response change nc observed NUMBER NUMBER NUMBER NUMBER patients respectively patients presented normal psa value treatment previous endocrine therapy NUMBER patients elevated psa value treatment showed complete response patients showed psa failure median period NUMBER months longer necessary minimum toxicity good clinical responses observed following proton beam therapy prostate cancer patients organ confined treatment related t1 t2b prostate specific follow follow short term t1 t2